LB-102 (100 mg tablet)

Drug identity checked against registry records

Also recorded as LB-102

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute SchizophreniaNCT07363577LBRXPhase 3Recruiting2027-06Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.